Showing the single result
Recently Gilead released Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg), with the claim that it was the first pan-genotypic, single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C virus (HCV) infection.
SHIPMENT PERIOD: Monday 7am to Friday 5pm. All packages are sent discreetly. Dismiss